VOR
Vor Biopharma Inc
NASDAQ: VOR · HEALTHCARE · BIOTECHNOLOGY
$14.33
+2.14% today
Updated 2026-04-30
Market cap
$702.43M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-70.50
Dividend yield
—
52W range
$3 – $66
Volume
1.1M
WallStSmart proprietary scores
32
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$37.50
+161.69%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-23.11M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-92.09M | $-117.86M | $-116.91M | $-695.98M | $1.72B |
| EPS | — | — | — | — | $-70.50 |
| Free cash flow | $-93.61M | $-101.36M | $-99.89M | $-143.65M | $-23.11M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Vor Biopharma Inc trades at $14.33. Our Smart Value Score of 32/100 indicates the stock is weak.
Frequently asked questions
What is Vor Biopharma Inc's stock price?
Vor Biopharma Inc (VOR) trades at $14.33.
Is Vor Biopharma Inc overvalued?
Smart Value Score 32/100 (Grade F, Strong Sell).
What is the price target of Vor Biopharma Inc (VOR)?
The analyst target price is $37.50, representing +161.7% upside from the current price of $14.33.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-125.40%
Beta1.92
50D MA$14.85
200D MA$22.89
Shares out0.05B
Float0.04B
Short ratio—
Avg volume1.1M
Performance
1 week+1.59%
1 month-19.32%
3 months+7.92%
YTD+7.26%
1 year—
3 years—
5 years—